1. Home
  2. DLTH vs CRDL Comparison

DLTH vs CRDL Comparison

Compare DLTH & CRDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Duluth Holdings Inc. Class B

DLTH

Duluth Holdings Inc. Class B

HOLD

Current Price

$4.43

Market Cap

138.0M

ML Signal

HOLD

Logo Cardiol Therapeutics Inc.

CRDL

Cardiol Therapeutics Inc.

HOLD

Current Price

$1.06

Market Cap

132.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DLTH
CRDL
Founded
1989
2017
Country
United States
Canada
Employees
N/A
N/A
Industry
Clothing/Shoe/Accessory Stores
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
138.0M
132.6M
IPO Year
2015
2017

Fundamental Metrics

Financial Performance
Metric
DLTH
CRDL
Price
$4.43
$1.06
Analyst Decision
Buy
Strong Buy
Analyst Count
1
2
Target Price
$7.00
$8.50
AVG Volume (30 Days)
243.8K
344.3K
Earning Date
06-04-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
64.12
N/A
EPS
N/A
N/A
Revenue
$565,184,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$2.80
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.02
$0.88
52 Week High
$5.09
$1.71

Technical Indicators

Market Signals
Indicator
DLTH
CRDL
Relative Strength Index (RSI) 57.76 40.93
Support Level $2.80 $0.99
Resistance Level $5.09 $1.10
Average True Range (ATR) 0.34 0.04
MACD -0.01 0.01
Stochastic Oscillator 46.22 60.00

Price Performance

Historical Comparison
DLTH
CRDL

About DLTH Duluth Holdings Inc. Class B

Duluth Holdings Inc is an apparel brand in the United States. The company offers shirts, pants, and casual wear for men and women under brands like Alaskan Hardgear, Armachillo, Ballroom, Cab Commander, Crouch Gusset, Dry on the Fly, Duluth Trading Co, Duluthflex, Fire Hose, Longtail T, No Polo Shirt, No Yank, Wild Boar, and others. The Company's revenue consists of the sale of apparel, footwear, and hard goods. The company operates in a single operating segment.

About CRDL Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc is a late-stage life sciences company focused on advancing the development of anti-inflammatory and anti-fibrotic therapies for heart disease. Its primary small-molecule candidate, CardiolRx, targets inflammasome pathway activation, which is involved in the development of inflammation and fibrosis in conditions such as pericarditis, myocarditis, and heart failure. The CardiolRx program includes the completed Phase II MAVERIC-Pilot study and the ongoing Phase III MAVERIC trial for the treatment of pericarditis. The ARCHER program evaluated CardiolRx in acute myocarditis through a completed Phase II study. The company is also developing CRD-38, a novel subcutaneous drug formulation for treating inflammatory heart conditions, including heart failure.

Share on Social Networks: